全文获取类型
收费全文 | 13325篇 |
免费 | 1321篇 |
国内免费 | 100篇 |
专业分类
耳鼻咽喉 | 113篇 |
儿科学 | 394篇 |
妇产科学 | 247篇 |
基础医学 | 1952篇 |
口腔科学 | 457篇 |
临床医学 | 1403篇 |
内科学 | 2648篇 |
皮肤病学 | 348篇 |
神经病学 | 1136篇 |
特种医学 | 693篇 |
外科学 | 2053篇 |
综合类 | 307篇 |
一般理论 | 11篇 |
预防医学 | 1306篇 |
眼科学 | 173篇 |
药学 | 742篇 |
2篇 | |
中国医学 | 6篇 |
肿瘤学 | 755篇 |
出版年
2022年 | 83篇 |
2021年 | 208篇 |
2020年 | 156篇 |
2019年 | 198篇 |
2018年 | 209篇 |
2017年 | 203篇 |
2016年 | 207篇 |
2015年 | 216篇 |
2014年 | 369篇 |
2013年 | 523篇 |
2012年 | 717篇 |
2011年 | 769篇 |
2010年 | 479篇 |
2009年 | 396篇 |
2008年 | 748篇 |
2007年 | 745篇 |
2006年 | 680篇 |
2005年 | 650篇 |
2004年 | 634篇 |
2003年 | 574篇 |
2002年 | 590篇 |
2001年 | 271篇 |
2000年 | 252篇 |
1999年 | 226篇 |
1998年 | 217篇 |
1997年 | 195篇 |
1996年 | 178篇 |
1995年 | 159篇 |
1994年 | 153篇 |
1993年 | 150篇 |
1992年 | 196篇 |
1991年 | 197篇 |
1990年 | 195篇 |
1989年 | 161篇 |
1988年 | 215篇 |
1987年 | 164篇 |
1986年 | 159篇 |
1985年 | 155篇 |
1984年 | 131篇 |
1983年 | 119篇 |
1982年 | 138篇 |
1981年 | 114篇 |
1980年 | 103篇 |
1979年 | 103篇 |
1978年 | 107篇 |
1977年 | 78篇 |
1976年 | 88篇 |
1975年 | 96篇 |
1974年 | 82篇 |
1973年 | 90篇 |
排序方式: 共有10000条查询结果,搜索用时 9 毫秒
1.
Peter G. Danias Thomas H. Hauser George Katsimaglis Rene M. Botnar Warren J. Manning 《Herz》2003,15(4):90-98
Coronary magnetic resonance angiography (CMRA) is a technique in clinical evolution. Current clinical applications include assessment for coronary anomalies, aneurysms, bypass graft patency, and, in experienced centers, the exclusion of proximal and multivessel coronary artery disease (CAD). As local expertise increases and more extensive multicenter data become available, additional applications will be established. CMRA promises to supplement and in some cases obviate the need for X-ray contrast angiography, and to expand our understanding of the pathophysiology of CAD. Zusammenfassung Die Magnetresonanzangiographie der Koronargefäße (CMRA) ist eine sich ständig weiterentwickelnde Technik. Etablierte Anwendungen sind zurzeit die Beurteilung von koronaren Anomalien, Aneurysmen und der Durchgängigkeit von Bypasses. Auch der Ausschluss proximaler Koronarstenosen und einer koronaren Mehrgefäßerkrankung ist in einigen spezialisierten Zentren möglich. Mit zunehmender Erfahrung der jeweiligen Anwender und der Verfügbarkeit von Ergebnissen großer multizentrischer Studien können zukünftig weitere klinische Anwendungen etabliert werden. In der Zukunft könnte die CMRA ergänzende Informationen zur Indikationsstellung einer konventionellen Röntgenangiographie bringen und in einigen Fällen diese Untersuchung sogar ersetzen. Die CMRA wird unseren Einblick in die Pathophysiologie der koronaren Herzerkrankung sicher erweitern. 相似文献
2.
Jonathan Halford Gandis Mazeika Susan Slifer Marcy Speer Ann M Saunders Warren J Strittmatter Joel C Morgenlander 《Movement disorders》2006,21(4):540-542
Ninety-seven inpatients with tardive dyskinesia (average AIMS score = 13), the majority of whom were schizophrenic, were studied. Forty patients were Caucasian, and 57 were African-American. The APOE genotypes of these patients were compared to previously published genotypes of controls and with previously published studies of APOE genotypes in patients with schizophrenia. There were no significant differences in APOE allele frequencies comparing the African-American tardive dyskinesia population and the African-American control groups. In contrast, significant (< 0.05) P values were obtained comparing the Caucasian tardive dyskinesia population to the Caucasian controls, when comparing allele frequencies and genotypic frequencies. This study suggests that Caucasians bearing an APOE2 allele are at increased risk of developing tardive dyskinesia, whereas African-Americans are not. APOE genotype-specific risks of both tardive dyskinesia and Alzheimer's disease that vary across populations could be due to recruitment of patients or controls or could be due to modifying effects of differing genetic or environmental backgrounds. The mechanism by which the APOE2 allele increases risk of tardive dyskinesia is not known. Further information about the mechanisms of increased risk of tardive dyskinesia could result in stratification of prescribing practices weighing the costs of medications against the relative risk of side effects. 相似文献
3.
4.
Bartczak Andi Weiss; Sangaiah Ramiah; Ball Louise M.; Warren Sarah H.; Gold Avram 《Mutagenesis》1987,2(2):101-105
Many polycyclic aromatic hydrocarbons containing peripherallyfused cyclopenta rings are believed to be activated primarilyby epoxidation of the cyclopenta ring. The cyclopenta epoxidesof a series of four cyclopenta benzanthracene derivatives, benz[e]aceanthrylene-5,6-oxide,benz[j]ace-anthrylene-1,2-oxide, benz(l)anthrylene-1,2-oxideand benz[k]acephenaceanthrylene-4,5-oxide were synthesized fromtheir parent hydrocarbons by formation of the bromohydrin followedby dehydrobromination, and characterized by u.v. vis,and 1H n.m.r. spectroscopy and mass spectrometry. The mutagenicityof these compounds was investigated in the Ames plate incorporationassay with Salmonella typhimurium strain TA98. All the oxideswere active without exogenous metabolic activation (170320His+ revertants per nanomole) and also toxic above 0.5 µg/plate.Addition of S9 protein did not increase, and generally decreased,the mutagenicity of the oxides, while toxicity was largely unchanged.These results are consistent with the postulated role of cyclopentaoxides as major contributors to the mutagenicity of the parentcompounds in the Ames assay. 相似文献
5.
6.
7.
Birgit T Priest Kenneth M Blumenthal Jaime J Smith Vivien A Warren McHardy M Smith 《Toxicon》2007,49(2):194-201
The tarantula venom peptides ProTx-I and ProTx-II inhibit voltage-gated sodium channels by shifting their voltage dependence of activation to a more positive potential, thus acting by a mechanism similar to that of potassium channel gating modifiers such as hanatoxin and VSTX1. ProTx-I and ProTx-II inhibit all sodium channel (Nav1) subtypes tested with similar potency and represent the first potent peptidyl inhibitors of TTX-resistant sodium channels. Like gating modifiers of potassium channels, ProTx-I and ProTx-II conform to the inhibitory cystine knot motif, and ProTx-II was demonstrated to bind to sodium channels in the closed state. Both toxins have been synthesized chemically, and ProTx-II, produced by recombinant means, has been used to map the interaction surface of the peptide with the Nav1.5 channel. In comparison, beta-scorpion toxins activate sodium channels by shifting the voltage dependence of activation to more negative potentials, and together these peptides represent valuable tools for exploring the gating mechanism of sodium channels. 相似文献
8.
9.
10.